Our people–a story of
competence and collaboration


Cultivating a diverse set of expertise and knowledge.

We employ an exemplary set of professionals with diverse skill sets, all working toward a common goal—invested in the health and care of the patient, knowing financial returns follow well-being. Our people have come together from all over the world and represent a culture of competence and collaboration that is shaping Nan Fung Life Sciences for generations to come.


We’re solving critical challenges. Be part of the answer.
Meet our exemplary team

Meng Gao

Chief Investment Officer, Nan Fung Group
Managing Partner, Pivotal bioVenture Partners (China)



Engrail Therapeutics and The Texas A&M University System Enter Licensing Agreement for Elesclomol in Disorders of Mitochondrial Copper Metabolism

SAN DIEGO–(BUSINESS WIRE)–Engrail Therapeutics™ (Engrail) (the Company), a neuroscience company focused on the acquisition, development and commercialization of patient-centric therapies…

The cash won't stop for Exscientia as it makes a $300M+ Nasdaq debut

Thursday, too, saw Exscientia raise more than just the IPO. In conjunction with the pricing, the Oxford, UK-based biotech got…

Obsidian Therapeutics Announces Closing of $115 Million Series B Financing

Funding to Advance Pipeline of Engineered TIL Therapies for Solid Tumors into Clinical Studies Existing investors Atlas Venture, Vertex Ventures…

Evommune Inc., Completes $83 Million Series A Financing to Advance Development of Unique Chronic Inflammation Pipeline

The financing enables Evommune to continue the research and development of transformative therapies through both industry and academic collaborations to…